JJ’s stock surrenders early gains as weak sales guidance offsets earnings beat
Jan 22, 2025
Medtech and drug company’s 2025 sales guidance is below consensus
https://www.marketwatch.com/story/j-js-earnings-beat-estimates-but-guidance-is-mixed-af40c571?mod=mw_rss_topstories
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service